“…We acknowledge that the main limitation of this trial was that it was not randomized. This study is the first, to our knowledge, to demonstrate the relative importance of the radiation delivery methods we use in patients in terms of dosimetry, cost, and clinical analysis (5,6), even within the field of IMRT. High-quality evidence for many of our treatment techniques is still very much lacking, and with new techniques constantly becoming available, it should not be considered trivial to create trials comparing novel delivery techniques, for example, in the field of stereotactic body radiation therapy.…”